Kathleen Shannon‐Dorcy

Fred Hutch Cancer Center — United States

Medicine · Health Sciences

14h-index1.7kcitations32works0.02yr avg
OpenAlex↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Acute Myeloid Leukemia Research(13), Hematopoietic Stem Cell Transplantation(10), Neutropenia and Cancer Infections(6), Antifungal resistance and susceptibility(5), Multiple Myeloma Research and Treatments(5)

Publications32 total

Outcomes after hematopoietic cell transplantation among non-English- compared to English-speaking recipients
Bone Marrow Transplantation·2022· 8 citedOpen Access
Survival Time is Problematic as an Indicator of an anti- AML Drug’s Effectiveness
Clinical Lymphoma Myeloma & Leukemia·2017
CLINICAL OBSERVATIONS, INTERVENTIONS, AND THERAPEUTIC TRIALS Selective Ablation of Acute Myeloid Leukemia Using Antibody-Targeted Chemotherapy: A Phase I Study of an Anti-CD33 Calicheamicin Immunoconjugate
2017
Caring to Learn and Learning to Care
Journal of Correctional Health Care·2017· 24 citedOpen Access
Essential Elements of an Effective Prison Hospice Program
American Journal of Hospice and Palliative Medicine®·2015· 40 citedOpen Access
Idarubicin, cytarabine, and pravastatin as induction therapy for untreated acute myeloid leukemia and high‐risk myelodysplastic syndrome
American Journal of Hematology·2015· 28 citedOpen Access
Follow-up of Related Stem Cell Donors One Week Post Donation
Biology of Blood and Marrow Transplantation·2015Open Access
Idarubicin, Cytarabine and Pravastatin As Induction Therapy for Untreated Acute Myeloid Leukemia and High-Risk Myelodysplastic Syndrome
Blood·2014· 1 cited
Value of routine ‘day 14’ marrow exam in newly diagnosed AML
Leukemia·2014· 23 cited
Outpatient bendamustine and idarubicin for upfront therapy of elderly acute myeloid leukaemia/myelodysplastic syndrome: a phase I/II study using an innovative statistical design
British Journal of Haematology·2014· 2 citedOpen Access
Building Capacity for the Future of Hematopoetic Cell Transplant Nursing
Biology of Blood and Marrow Transplantation·2014Open Access
NCI Common Toxicity Criteria and Mortality After Chemotherapy for Acute Myeloid Leukemia (AML)
Blood·2012· 1 cited
Safety and Efficacy of Bendamustine and Idarubicin in Combination Therapy for Patients Age ≥50 with Untreated Acute Myeloid Leukemia and High-Risk Myelodysplastic Syndrome – Results From a Phase I/II Adaptive Design Study.
Blood·2012· 1 cited
Frequency of Allogeneic Hematopoietic Cell Transplantation Among High-Risk AML Patients in First Complete Remission at an Academic Center
Biology of Blood and Marrow Transplantation·2012· 1 citedOpen Access
Survival After Failure of Initial Therapy for Newly-Diagnosed or Relapsed/Refractory AML At An Academic Center: Subsequent Clinical Trial Vs. Not
Blood·2011
Outpatient management following intensive induction chemotherapy for myelodysplastic syndromes and acute myeloid leukemia: a pilot study
Haematologica·2011· 35 citedOpen Access
"I Had Already Made Up My Mind"
Cancer Nursing·2011· 36 citedOpen Access
462: Domains of Decision making in Quaternary HSCT Research
Biology of Blood and Marrow Transplantation·2008Open Access
Decision-making in the diagnosis and treatment of leukemia
Seminars in Oncology Nursing·2003· 3 cited
Nursing Implications of Mylotarg®: A Novel Antibody-Targeted Chemotherapy for CD33+Acute Myeloid Leukemia in First Relapse
Oncology nursing forum·2002· 2 cited
page 1 of 2Next →

Frequent Co-authors

Elihu H. Estey(10), Pamela S. Becker(9), John M. Pagel(8), Frederick R. Appelbaum(7), Roland B. Walter(7), Jack W. Singer(6), John Nemunaitis(6), Paul C. Hendrie(6), FR Appelbaum(5), Rainer Storb(5), Bart L. Scott(5), F R Appelbaum(4), C. Dean Buckner(4), Mazyar Shadman(4), Raya Mawad(4), Carol Dean(4), Vicky Sandhu(4), Jack M. Lionberger(4), Ravinder Sandhu(4), Eric L. Sievers(3)